Coya Therapeutics, Inc. SEC filings COYA
Coya Therapeutics, Inc. has 230 filings in SEC EDGAR's recent list, going back to Jan 5, 2021. Its latest annual report, Form ARS, was filed on May 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 14, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Other events
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Other events
|
Sep 15, 2026 | Sep 15, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 7, 2026 | Mar 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2026 | Jun 25, 2026 |
| ARS | Annual report to shareholders | May 13, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | May 13, 2026 | — |
| DEF 14A | Proxy statement | May 13, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Material agreement
|
May 12, 2026 | May 12, 2026 |
| 424B5 | Prospectus supplement | May 12, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2026 | Mar 29, 2026 |
| EFFECT | Filing | Mar 20, 2026 | — |
| 424B3 | Prospectus | Mar 20, 2026 | — |
| CORRESP | Letter to the SEC | Mar 19, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2026 | — |
| S-3 | Shelf registration | Mar 16, 2026 | — |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 30, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Other events
|
Jan 20, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Other events
|
Dec 17, 2025 | Dec 16, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 27, 2025 | Oct 23, 2025 |
| 424B5 | Prospectus supplement | Oct 27, 2025 | — |
| 424B5 | Prospectus supplement | Oct 23, 2025 | — |
| 8-K |
Current report
Other events
|
Sep 2, 2025 | Aug 29, 2025 |
| EFFECT | Filing | Aug 19, 2025 | — |
| 424B7 | Filing | Aug 19, 2025 | — |
| CORRESP | Letter to the SEC | Aug 18, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| S-3 | Shelf registration | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Other events
|
Jul 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2025 | Jun 26, 2025 |
| ARS | Annual report to shareholders | May 16, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 16, 2025 | — |
| DEF 14A | Proxy statement | May 16, 2025 | Jun 26, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 13, 2025 | May 13, 2025 |
| 10-K/A | Amended annual report | Apr 28, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 18, 2025 | Mar 18, 2025 |
| S-8 | Employee stock plan registration | Jan 30, 2025 | — |
| EFFECT | Filing | Nov 29, 2024 | — |
| 424B3 | Prospectus | Nov 29, 2024 | — |
| CORRESP | Letter to the SEC | Nov 26, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2024 | — |
| S-3 | Shelf registration | Nov 20, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 5, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 31, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2024 | Oct 29, 2024 |
| D | Filing | Oct 28, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Oct 22, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 19, 2024 | Aug 16, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Other events
|
Jul 15, 2024 | Jul 12, 2024 |
| 424B3 | Prospectus | Jun 24, 2024 | — |
| EFFECT | Filing | Jun 21, 2024 | — |
| CORRESP | Letter to the SEC | Jun 20, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2024 | — |
| S-3 | Shelf registration | Jun 14, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jun 5, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 20, 2024 | May 17, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 8, 2024 | May 8, 2024 |
| DEFA14A | Additional proxy material | Mar 29, 2024 | — |
| ARS | Annual report to shareholders | Mar 28, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 28, 2024 | — |
| DEF 14A | Proxy statement | Mar 28, 2024 | May 8, 2024 |
| 10-K | Annual report | Mar 19, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 19, 2024 | Mar 19, 2024 |
| 8-K |
Current report
Other events
|
Jan 19, 2024 | Jan 19, 2024 |
| 424B3 | Prospectus | Jan 16, 2024 | — |
| EFFECT | Filing | Jan 12, 2024 | — |
| CORRESP | Letter to the SEC | Jan 10, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 9, 2024 | — |
| S-3 | Shelf registration | Jan 4, 2024 | — |
| D | Filing | Dec 20, 2023 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 20, 2023 | Dec 19, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Dec 6, 2023 | Dec 5, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 21, 2023 | Aug 18, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 10, 2023 | Jul 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 12, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Other events
|
May 23, 2023 | May 22, 2023 |
| DEFA14A | Additional proxy material | May 19, 2023 | — |
| ARS | Annual report to shareholders | May 19, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | May 19, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 16, 2023 | May 16, 2023 |
| 424B4 | Prospectus | May 12, 2023 | — |
| EFFECT | Filing | May 10, 2023 | — |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| POS AM | Filing | May 8, 2023 | — |
| 10-K/A | Amended annual report | May 1, 2023 | Dec 31, 2022 |
| S-8 | Employee stock plan registration | Apr 14, 2023 | — |
| 10-K | Annual report | Mar 29, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 22, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 21, 2023 | Mar 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 1, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Other events
|
Jan 25, 2023 | Jan 25, 2023 |
| 424B4 | Prospectus | Dec 30, 2022 | — |
| CERT | Filing | Dec 29, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 28, 2022 | — |
| EFFECT | Filing | Dec 28, 2022 | — |
| 8-A12B | Filing | Dec 27, 2022 | — |
| CORRESP | Letter to the SEC | Dec 23, 2022 | — |
| CORRESP | Letter to the SEC | Dec 23, 2022 | — |
| CORRESP | Letter to the SEC | Dec 13, 2022 | — |
| S-1/A | Amended registration statement | Dec 13, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2022 | — |
| FWP | Free writing prospectus | Dec 6, 2022 | — |
| CORRESP | Letter to the SEC | Dec 5, 2022 | — |
| S-1/A | Amended registration statement | Dec 5, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2022 | — |
| SEC STAFF LETTER | Filing | Nov 23, 2022 | — |
| CORRESP | Letter to the SEC | Nov 18, 2022 | — |
| S-1 | Registration statement | Nov 18, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2022 | — |
| DRSLTR | Filing | Oct 28, 2022 | — |
| DRS/A | Filing | Oct 28, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2022 | — |
| DRSLTR | Filing | Oct 7, 2022 | — |
| DRS/A | Filing | Oct 7, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2022 | — |
| DRS | Filing | Aug 19, 2022 | — |
| D | Filing | May 20, 2022 | — |
| D | Filing | Jan 5, 2021 | — |
Showing 147 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- COYA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1835022
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.